Helix BioPharma (TSE:HBP)
TSX:HBP
Canadian Market
Holding TSE:HBP?
Track your performance easily

Helix BioPharma (HBP) Cash flow

25 Followers

Helix BioPharma Cash Flow

TSE:HBP's free cash flow for Q4 2024 was C$―. For the 2024 fiscal year, TSE:HBP's free cash flow was decreased by C$0.00 and operating cash flow was C$-747.00K. See a summary of the company’s cash flow.
Cash Flow
TTM
Jul 24Jul 23Jul 22Jul 21Jul 20
Operating Cash Flow
C$ -5.22MC$ -5.22MC$ -5.53MC$ -6.51MC$ -9.30MC$ -10.83M
Investing Cash Flow
C$ -14.00KC$ -14.00KC$ -5.00K-C$ 2.02MC$ 1.70M
Financing Cash Flow
C$ 5.51MC$ 5.51MC$ 3.09MC$ 6.21MC$ 6.56MC$ 13.10M
Cash Flow From Discontinued Operation
------
Other Cash Adjustment Inside Changein Cash
------
End Cash Position
C$ 3.55MC$ 1.08MC$ 808.00KC$ 3.25MC$ 3.56MC$ 4.24M
Income Tax Paid Supplemental Data
------
Interest Paid Supplemental Data
------
Issuance Of Capital Stock
C$ 5.51MC$ 5.51MC$ 5.15MC$ 2.99MC$ 3.56MC$ 12.19M
Issuance Of Debt
--C$ -2.06M-C$ 3.00MC$ -151.00K
Repayment Of Debt
----C$ -158.00KC$ -151.00K
Free Cash Flow
---C$ -6.51MC$ -9.30MC$ -10.79M
Domestic Sales
------
Foreign Sales
------
Currency in CAD

Helix BioPharma Cash Flow

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis